| 巴桑拉姆,李杏翠,次仁德吉.西藏自治区人民医院实施国家重点监控药品干预成效分析[J].中国药事,2024,38(3):360-366 |
| 西藏自治区人民医院实施国家重点监控药品干预成效分析 |
| Analysis on the Eff ect of Key Intervention on Key Monitoring Drugs in People'sHospital of the Tibet Autonomous Region |
| 投稿时间：2023-11-01 |
| DOI：10.16153/j.1002-7777.2024.03.016 |
| 中文关键词: 重点监控药品 质控体系 合理用药 干预 成效分析 |
| 英文关键词: key monitoring drugs quality control system rational drug use intervention analysis of eff ect |
| 基金项目:西藏自治区自然科学基金组团式援助医学项目[编号 XZ2020ZR-ZY25（Z）] |
|
| 摘要点击次数: 410 |
| 全文下载次数: 147 |
| 中文摘要: |
| 目的：评价西藏自治区人民医院对重点监控药品进行重点干预的成效，为优化重点监控药品干预策略、促进临床合理用药提供参考。方法：西藏自治区人民医院于2020年制订《西藏自治区人民医院重点监控药品管理规定》，建立《西藏自治区人民医院重点监控药品目录》，同时开展重点监控药品处方及医嘱专项点评、采取点评结果公示及绩效考核挂钩等目标性干预措施，对比西藏自治区人民医院2019年4月-2020年3月（干预前）与2020年4月-2021年3月（干预后第一年）及2021年4月-2022年3月（干预后第二年）重点监控药品临床使用数据变化，评价重点干预措施对该类药品的管理成效及临床使用的影响。结果：该院干预后第一年及第二年的重点监控药品销售金额分别为1427.01万元、1388.12万元，低于干预前的2004.29万元；干预后重点监控药品销售金额占药品总销售金额比例分别为8.33%、7.47%，低于干预前的10.11%。重点监控药品各品种的DDC普遍较高，患者的经济负担较重。结论：西藏自治区人民医院重点监控药品的干预取得了一定成效，但医院应在此基础上采取有力措施，提高重点监控药品合理使用，进一步减轻患者经济负担。 |
| 英文摘要: |
| Objective: To evaluate the effect of key intervention on key monitoring drugs in the People’sHospital of the Tibet Autonomous Region, so as to provide references for optimizing intervention strategy ofkey monitoring drugs and promoting rational clinical drug use. Methods: The Regulations on the Managementof Key Monitoring Drugs in People's Hospital of the Tibet Autonomous Region of were formulated and theLists of Key Monitoring Drugs in People's Hospital of the Tibet Autonomous Region were established in 2020.At the same time, targeted intervention measures such as special reviews on key monitoring drug prescriptions and medical orders, publicity of review results and performance appraisal linkage were carried out. The eff ect of key interventions on the management and clinical use of these drugs was evaluated by comparing the changes ofclinical use data of key monitoring drugs in People's Hospital of the Tibet Autonomous Region from April 2019to March 2020 (before intervention), April 2020 to March 2021 (the fi rst year after intervention) and April 2021to March 2022 (the second year after intervention). Results: The sales amount of key monitoring drugs in the fi rstyear and the second year after the intervention was 14.2701 million yuan and 13.8812 million yuan, respectively,which was lower than 20.0429 million yuan before the intervention, After the intervention, the proportion ofthe consumption sum of key monitoring drugs in the total consumption sum of drugs was 8.33% and 7.47%,respectively, which was lower than the 10.11% before the intervention. The DDC of all key monitoring drugswere higher, and the economic burden of patients was heavier. Conclusion: The intervention of key monitoringdrugs in People’s Hospital of the Tibet Autonomous Region has achieved certain results, but it is still necessary totake long-term and continuous eff ective measures to improve the rational use of key monitoring drugs and furtherreduce the economic burden of patients. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |